0.1406
Finanzdaten der Vivos Therapeutics Inc-Aktie (VVOS)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
0.23%
5.153
|
5.141 | 3.824 | 6.783 | 3.82 |
| Gross Profit |
3.47%
2.953
|
3.059 | 2.988 | 3.937 | 2.11 |
| Operating Expenses |
19.60%
7.778
|
9.674 | 9.37 | 8.671 | 6.975 |
| Interest Income/Expense |
0.00%
1.10
|
1.10 | 0.80 | 0.50 | - |
| Depreciation and Amortization |
12.33%
0.51
|
0.454 | 0.442 | 0.384 | 0.306 |
| Operating Income/Loss |
27.06%
-4.825
|
-6.615 | -6.382 | -4.734 | -4.865 |
| Income/Loss From Continuing Operations Before Tax |
28.74%
-5.523
|
-7.751 | -6.954 | -5.40 | -5.013 |
|
|
28.74%
-5.523
|
-7.751 | -6.894 | -5.40 | -5.013 |
| Attributable To Noncontrolling Interest |
39.13%
-0.042
|
-0.069 | - | - | - |
| Basic Average Shares |
20.83%
17.68
|
14.63 | - | 10.96 | 9.0872 |
| Diluted Average Shares |
20.83%
17.68
|
14.63 | - | 10.96 | 9.0872 |
| Basic Earnings Per Share |
40.38%
-0.31
|
-0.52 | - | -0.49 | -0.55 |
| Diluted Earnings Per Share |
40.38%
-0.31
|
-0.52 | - | -0.49 | -0.55 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):